Yüklüyor......
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
Direct oral anticoagulants (DOACs) were developed to compensate for the demerits of warfarin. In Japan, three factor Xa inhibitors are used for the treatment of venous thromboembolism (VTE): edoxaban, rivaroxaban, and apixaban. Despite problems, such as the inability to monitor their effect and the...
Kaydedildi:
| Yayımlandı: | J Atheroscler Thromb |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Japan Atherosclerosis Society
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5453680/ https://ncbi.nlm.nih.gov/pubmed/28392512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17005 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|